News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

WuXi PharmaTech Co., Ltd. Schedules Second-Quarter 2013 Earnings Release


7/15/2013 10:32:22 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SHANGHAI, July 15, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2013 after the New York Stock Exchange closes on Monday, August 12, 2013 (which will be Tuesday morning, August 13, 2013 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, August 13, 2013, to discuss the second-quarter 2013 financial results and recent business activities. The conference call may be accessed by calling:

Australia

1800 801 825

Belgium

0800 784 01

Canada

1855 842 3490

China

4001 200 539

France

0800 916 599

Germany

0800 1899 399

Hong Kong

800 905 927

Hong Kong (toll)

+852 5808 3202

India

000 800 100 8255

Indonesia

00180 301 91840

Ireland

1800 720 105

Italy

800 875 577

Japan

0120 271 900

Malaysia

1800 816 107

Netherlands

0800 0234 240

New Zealand

0800 452 905

Singapore

800 616 3222

South Korea

00798 6136 1434

Sweden

0207 968 70

Switzerland

0800 837 001

Taiwan

0080 161 5189

United Kingdom

0800 015 9725

United KingdomLondon (toll)

44 (0) 20 3078 7622

United States

1855 298 3404

United StatesNew York (toll)

+1 631 5142 526

Other countries (toll)

+65 6823 2299

Conference ID:

1007691

A telephone replay will be available two hours after the call's completion at:

Australia

1800 008 585

Belgium

0800 11 797

Canada

1866 4783 460

China

4001 842 240

France

0800 904 160

Germany

0800 181 3763

Hong Kong

800 966 697

India

000 800 100 6647

Indonesia

0018 0306 12086

Ireland

1800 511 665

Italy

800 784 706

Japan

0066 3386 1031

Malaysia

1800 181 061

Netherlands

08000 232 153

New Zealand

0800 444 310

Singapore

800 616 2127

South Korea

00798 612 1058

Sweden

020 792 274

Switzerland

0800 564 016

Taiwan

00801 232 352

United Kingdom

0800 169 7301

United States

1866 846 0868

Conference ID:

1007691

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES